Benzinga's Top Upgrades, Downgrades For February 26, 2020

Loading...
Loading...

Upgrades

  • Jefferies changed the rating for Kratos Defense & Security Solutions Inc KTOS from Hold to Buy. In the fourth quarter, Kratos Defense & Security showed an EPS of $0.09, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $25.08 and a 52-week-low of $14.48. Kratos Defense & Security's stock last closed at $15.00 per share.
  • HSBC changed the rating for BanColombia SA CIB from Hold to Buy. In the fourth quarter, BanColombia showed an EPS of $0.60, compared to $1.28 from the year-ago quarter. The stock has a 52-week-high of $56.10 and a 52-week-low of $44.66. BanColombia's stock last closed at $49.01 per share.
  • For CME Group Inc CME, UBS upgraded the stock from Neutral to Buy. CME Group earned $1.52 in the fourth quarter, compared to $1.77 in the year-ago quarter. The stock has a 52-week-high of $224.91 and a 52-week-low of $161.05. CME Group's stock last closed at $208.32 per share.
  • Mizuho upgraded the stock for Sabra Health Care REIT Inc SBRA from Neutral to Buy. Interestingly, in the fourth quarter, Sabra Health Care REIT's EPS was $0.48. The stock has a 52-week-high of $24.95 and a 52-week-low of $17.31. Sabra Health Care REIT's stock last closed at $21.22 per share.
  • Piper Sandler upgraded the stock for Flagstar Bancorp Inc FBC from Neutral to Overweight. For the fourth quarter, Flagstar Bancorp had an EPS of $1.00, compared to year-ago quarter EPS of $0.72. The stock has a 52-week-high of $40.00 and a 52-week-low of $30.62. Flagstar Bancorp's stock last closed at $34.01 per share.
  • For Nevro Corp NVRO, Canaccord Genuity upgraded the stock from Hold to Buy. In the fourth quarter, Nevro showed an EPS of ($0.44), compared to ($0.32) from the year-ago quarter. The stock has a 52-week-high of $145.56 and a 52-week-low of $42.82. Nevro's stock last closed at $132.50 per share.
  • Canaccord Genuity changed the rating for Regeneron Pharmaceuticals Inc REGN from Hold to Buy. In the fourth quarter, Regeneron Pharmaceuticals showed an EPS of $7.50, compared to $6.84 from the year-ago quarter. The stock has a 52-week-high of $457.60 and a 52-week-low of $271.37. Regeneron Pharmaceuticals's stock last closed at $442.35 per share.

 

Downgrades

  • Bernstein downgraded the stock for Kosmos Energy Ltd KOS from Outperform to Market Perform. Kosmos Energy earned ($0.09) in the fourth quarter, compared to ($0.09) in the year-ago quarter. The stock has a 52-week-high of $7.55 and a 52-week-low of $3.67. Kosmos Energy's stock last closed at $3.73 per share.
  • SunTrust Robinson Humphrey downgraded the stock for PulteGroup Inc PHM from Buy to Hold. PulteGroup earned $1.14 in the fourth quarter, compared to $1.11 in the year-ago quarter. The stock has a 52-week-high of $47.37 and a 52-week-low of $25.24. PulteGroup's stock last closed at $43.35 per share.
  • For Nike Inc NKE, HSBC downgraded the stock from Buy to Hold. For the second quarter, Nike had an EPS of $0.70, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $105.62 and a 52-week-low of $77.07. Nike's stock last closed at $92.89 per share.
  • SunTrust Robinson Humphrey downgraded the stock for KB Home KBH from Buy to Hold. KB Home earned $1.31 in the fourth quarter, compared to $0.96 in the year-ago quarter. The stock has a 52-week-high of $40.51 and a 52-week-low of $21.69. KB Home's stock last closed at $36.73 per share.
  • SunTrust Robinson Humphrey downgraded the stock for D.R. Horton Inc DHI from Buy to Hold. D.R. Horton earned $1.00 in the first quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $62.54 and a 52-week-low of $37.81. D.R. Horton's stock last closed at $58.09 per share.
  • Baird downgraded the stock for A.O. Smith Corp AOS from Outperform to Neutral. In the fourth quarter, A.O. Smith showed an EPS of $0.56, compared to $0.74 from the year-ago quarter. The stock has a 52-week-high of $56.66 and a 52-week-low of $40.38. A.O. Smith's stock last closed at $40.95 per share.
  • Baird changed the rating for Regeneron Pharmaceuticals Inc REGN from Outperform to Neutral. Regeneron Pharmaceuticals earned $7.50 in the fourth quarter, compared to $6.84 in the year-ago quarter. The stock has a 52-week-high of $457.60 and a 52-week-low of $271.37. Regeneron Pharmaceuticals's stock last closed at $442.35 per share.
  • For AptarGroup Inc ATR, Morgan Stanley downgraded the stock from Overweight to Equal-Weight. In the fourth quarter, AptarGroup showed an EPS of $0.80, compared to $0.92 from the year-ago quarter. The stock has a 52-week-high of $126.19 and a 52-week-low of $99.21. AptarGroup's stock last closed at $106.98 per share.
  • Raymond James downgraded the stock for E*TRADE Financial Corp ETFC from Outperform to Market Perform. ETRADE Financial earned $0.84 in the fourth quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of $57.30 and a 52-week-low of $34.68. ETRADE Financial's stock last closed at $48.52 per share.
  • Raymond James downgraded the stock for Toll Brothers Inc TOL from Outperform to Market Perform. In the first quarter, Toll Brothers showed an EPS of $0.41, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $49.31 and a 52-week-low of $34.34. Toll Brothers's stock last closed at $44.27 per share.

 

Initiations

  • With a rating of Overweight, Morgan Stanley initiated coverage on 1Life Healthcare Inc ONEM. The price target is set at $27.00 for 1Life Healthcare. The stock has a 52-week-high of $28.58 and a 52-week-low of $17.52. 1Life Healthcare's stock last closed at $23.64 per share.
  • With a rating of Equal-Weight, Morgan Stanley initiated coverage on DTE Energy Co DTE. The price target is set at $130.00 for DTE Energy. In the fourth quarter, DTE Energy showed an EPS of $1.35, compared to $1.05 from the year-ago quarter. The stock has a 52-week-high of $135.67 and a 52-week-low of $120.08. DTE Energy's stock last closed at $128.14 per share.
  • BTIG Research initiated coverage on Broadridge Financial Solutions Inc BR with a Buy rating. The price target for Broadridge Financial Soln is set at $135.00. Broadridge Financial Soln earned $0.53 in the second quarter, compared to $0.56 in the year-ago quarter. The stock has a 52-week-high of $136.99 and a 52-week-low of $97.37. Broadridge Financial Soln's stock last closed at $112.48 per share.
  • For Diageo PLC DEO, Goldman Sachs initiated coverage, by setting the current rating at Buy. The stock has a 52-week-high of $176.22 and a 52-week-low of $152.31. Diageo's stock last closed at $152.57 per share.
  • With a rating of Buy, BTIG Research initiated coverage on Cerus Corp CERS. The price target is set at $7.00 for Cerus. Cerus earned ($0.12) in the fourth quarter, compared to ($0.12) in the year-ago quarter. The stock has a 52-week-high of $6.88 and a 52-week-low of $3.70. Cerus's stock last closed at $4.90 per share.
  • Piper Sandler initiated coverage on Avadel Pharmaceuticals PLC AVDL with an Overweight rating. The price target for Avadel Pharmaceuticals is set at $14.00. In the third quarter, Avadel Pharmaceuticals showed an EPS of ($0.24), compared to ($0.65) from the year-ago quarter. The stock has a 52-week-high of $10.75 and a 52-week-low of $1.03. Avadel Pharmaceuticals's stock last closed at $10.22 per share.
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInitiationstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...